Injectable GLP-1s like Ozempic and Mounjaro require specialized fill-finish capabilities and cold chain infrastructure
One study (from 1999) mentions the issue described above, but it is not a credible source for the following reasons: The study wasn't performed on normal human proteins or healthy, intact skin (instead, a blend of animal and human proteins, and the pH relationship issue developed only when a fatty acid byproduct was added to the mix)
Diagnosis of adenylosuccinate lyase deficiency by metabolomic profiling in plasma reveals a phenotypic spectrum
So that's only cancer that came up as a concern
Because many people access these medications through online platforms or busy primary care offices, patients often miss out on the counseling that helps manage side effects and support long-term results, says Joni Rampolla, RDN, a dietitian specializing in weight health and metabolic wellness and the founder of Nutrition Coaching 4U